Investor Relations

Esperion Therapeutics, Inc. is an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers.

Esperion Therapeutics is a publicly traded company (since 2013) and is listed on the NASDAQ Global Select Market under the symbol ESPR.

Esperion Therapeutics (NASDAQ: ESPR) 4:00 PM ET on Oct 17, 2014
Last Price Change Open Day High 52-Week High
0.84  up   (4.060%) 20.97 23.51 30.38
Volume Previous Close Day Low 52-Week Low
935,400 20.69 20.55 10.90

View all »   RSSRecent Releases

Oct 15, 2014
Esperion Therapeutics Prices Public Offering of Common Stock

Oct 14, 2014
Esperion Therapeutics Announces Proposed Public Offering of Common Stock